Kehua Biological announcement, the company's independent research and development of novel coronavirus (2019-nCoV) mutation nucleic acid detection kit (fluorescent PCR method) was shortlisted in the export "whitelist". The kit is used for identification and epidemiological surveillance of major mutants (including N501Y, HV69-70del, K417N, E484K, K417T and D614G) in throat swabs, nasal swabs and plasma of patients diagnosed by novel coronavirus.
科华生物：新冠病毒检测产品入围出口“白名单”
Kehua Biology: novel coronavirus testing products are shortlisted for export "whitelist"
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.